Mutations in the codon responsible for encoding BCAT1 have been identified in clinical GC samples, and these mutations result in higher enzymatic activity of BCAT1, which promotes BCAA catabolism and accelerates cell growth motility and tumor development. Here, BCAT1 is linked to neoplasm.